PDZ Protein Interactions Underlying NMDA Receptor-Mediated Excitotoxicity and Neuroprotection by PSD-95 Inhibitors
Open Access
- 12 September 2007
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 27 (37), 9901-9915
- https://doi.org/10.1523/jneurosci.1464-07.2007
Abstract
In neuronal synapses, PDZ domains [postsynaptic density-95 (PSD-95)/Discs large/zona occludens-1] of PSD-95 proteins interact with C termini of NMDA receptor [NMDAR (NR)] subunits, linking them to downstream neurotoxic signaling molecules. Perturbing NMDAR/PSD-95 interactions with a Tat peptide comprising the nine C-terminal residues of the NR2B subunit (Tat-NR2B9c) reduces neurons' vulnerability to excitotoxicity and ischemia. However, NR subunit C termini may bind many of >240 cellular PDZs, any of which could mediate neurotoxic signaling independently of PSD-95. Here, we performed a proteomic and biochemical analysis of the interactions of all known human PDZs with synaptic signaling proteins including NR1, NR2A–NR2D, and neuronal nitric oxide synthase (nNOS). Tat-NR2B9c, whose interactions define PDZs involved in neurotoxic signaling, was also used. NR2A–NR2D subunits and Tat-NR2B9c had similar, highly specific, PDZ protein interactions, of which the strongest were with the PSD-95 family members (PSD-95, PSD-93, SAP97, and SAP102) and Tax interaction protein 1 (TIP1). The PSD-95 PDZ2 domain bound NR2A–NR2C subunits most strongly (EC50, ∼1 μm), and fusing the NR2B C terminus to Tat enhanced its affinity for PSD-95 PDZ2 by >100-fold (EC50, ∼7 nm). IC50values for Tat-NR2B9c inhibiting NR2A–NR2C/PSD-95 interactions (∼1–10 μm) and nNOS/PSD-95 interactions (200 nm) confirmed the feasibility of such inhibition. To determine which of the PDZ interactions of Tat-NR2B9c mediate neuroprotection, one of PSD-95, PSD-93, SAP97, SAP102, TIP1, or nNOS expression was inhibited in cortical neurons exposed to NMDA toxicity. Only neurons lacking PSD-95 or nNOS but not PSD-93, SAP97, SAP102, or TIP1 exhibited reduced excitotoxic vulnerability. Thus, despite the ubiquitousness of PDZ domain-containing proteins, PSD-95 and nNOS above any other PDZ proteins are keys in effecting NMDAR-dependent excitotoxicity. Consequently, PSD-95 inhibition may constitute a highly specific strategy for treating excitotoxic disorders.Keywords
This publication has 62 references indexed in Scilit:
- Insights into the Molecular Evolution of the PDZ/LIM Family and Identification of a Novel Conserved Protein MotifPLOS ONE, 2007
- Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95–neuroliginNature Neuroscience, 2007
- A molecular-properties-based approach to understanding PDZ domain proteins and PDZ ligandsGenome Research, 2006
- Identification of MAGI-3 as a transforming growth factor-α tail binding proteinExperimental Cell Research, 2005
- Neonatal Hypoxia-Ischemia Differentially Upregulates MAGUKs and Associated Proteins in PSD-93–Deficient Mouse BrainStroke, 2003
- hINADl/PATJ, a Homolog of Discs Lost, Interacts with Crumbs and Localizes to Tight Junctions in Human Epithelial CellsOnline Journal of Public Health Informatics, 2002
- Selfotel in Acute Ischemic StrokeStroke, 2000
- SMART: a web-based tool for the study of genetically mobile domainsNucleic Acids Research, 2000
- Three Isoforms of Synaptic Scaffolding Molecule and Their CharacterizationOnline Journal of Public Health Informatics, 2000
- SAP102, a Novel Postsynaptic Protein That Interacts with NMDA Receptor Complexes In VivoNeuron, 1996